Most not long ago, it has been identified that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds into a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger and would not activate a